Boston Angel Investors →
Top Entrepreneurs' Advice →
Support Xconomy Detroit →
Incubator Guide →
Director, Silicon Flatirons Centers' Entrepreneurship Initiative
VP of Research & Policy, Ewing Marion Kauffman Foundation
Chair of the Dept. of Chemical Physiology
Partner, Third Rock Ventures
Co-Founder and CEO, Wetpaint
VP of Research and Special Initiatives, Google
Co-Founder, VP of Technology, Entropic Communications
NKT Therapeutics is developing drugs that target a class of immune cells known as natural killer T cells.
Seattle · 04/22/142:45 pm - 6:00 pm
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2014, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.